title: Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602.
authors.forename: Giuseppa
authors.initials: G
authors.lastname: Penna
authors.forename: Alessandro
authors.initials: A
authors.lastname: Allegra
authors.forename: Giuseppa
authors.initials: G
authors.lastname: Romeo
authors.forename: Andrea
authors.initials: A
authors.lastname: Alonci
authors.forename: Antonino
authors.initials: A
authors.lastname: Cannavò
authors.forename: Sabina
authors.initials: S
authors.lastname: Russo
authors.forename: Arianna
authors.initials: A
authors.lastname: D'Angelo
authors.forename: Annamaria
authors.initials: A
authors.lastname: Petrungaro
authors.forename: Caterina
authors.initials: C
authors.lastname: Musolino
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D003907:Dexamethasone / Q000008:administration & dosage; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D005260:Female; D015234:HLA-A Antigens / Q000032:analysis; D015235:HLA-B Antigens / Q000032:analysis; D015236:HLA-C Antigens / Q000032:analysis; D059866:HLA-DQ beta-Chains / Q000235:genetics*; D059811:HLA-DRB1 Chains / Q000235:genetics*; D006801:Humans; D007558:Italy; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology*; D011239:Prednisolone / Q000008:administration & dosage; D012720:Severity of Illness Index; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000276:immunology; D044465:White People / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D015234:HLA-A Antigens; D015235:HLA-B Antigens; D015236:HLA-C Antigens; D059866:HLA-DQ beta-Chains; C069051:HLA-DQB1 antigen; D059811:HLA-DRB1 Chains; C489631:HLA-DRB1*15:01 antigen; D013792:Thalidomide; D003907:Dexamethasone; D011239:Prednisolone; D000077269:Lenalidomide